Steven Yeh MD
Retinal Disease, Uveitis
Assistant Professor, Ophthalmology, Emory University School of Medicine
Join to View Full Profile
1365B Clifton Rd NEAtlanta, GA 30322
Phone+1 404-778-5070
Fax+1 404-778-4380
Dr. Yeh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of Medicine/Cullen Eye InstituteResidency, Ophthalmology, 2003 - 2006- Baylor College of MedicineInternship, Transitional Year, 2002 - 2003
- Baylor College of MedicineClass of 2002
Certifications & Licensure
OR State Medical License 2008 - Present
NE State Medical License 2020 - 2026
GA State Medical License 2010 - 2022
MD State Medical License 2006 - 2015
American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- The Effect of Metagenomic Sequencing on Patient Clinical Outcomes for Intraocular Infections: A Multicenter Randomized Controlled Trial.Jessica G Shantha, Kareem Moussa, Wipada Laovirojjanakul, Steven Yeh, Edmund Tsui
American Journal of Ophthalmology. 2025-07-11 - 4 citationsCommon Practice Patterns in the Diagnosis and Management of Acute Retinal Necrosis: A Survey Study of Uveitis Specialists.Isabel K Ray, Lucia Sobrin, Ramana Moorthy, Steven Yeh, Jennifer E Thorne
Ocular Immunology and Inflammation. 2025-07-01 - Understanding the pathogenesis of uveitis in Ebola virus disease survivors: a study protocol for clinical, molecular virologic, and immunologic characterization.Caleb D Hartley, Susanne Linderman, Tolulope Fashina, Laura Ward, Carolyn Drews-Botsch
Medrxiv. 2025-05-21
Press Mentions
Medical Research Highlights, February 2025February 15th, 2025- RWC Update: Removal of a Dislocated Ganciclovir Implant; The Role of Early Vitrectomy for Endophthalmitis; Inherited Retinal DiseaseJuly 1st, 2024
- Adverum Biotechnologies Reports Recent Business Progress and Third Quarter 2020 Financial ResultsNovember 5th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
